AFP.AX · AFT PHARMACEUTICALS LIMITED
Australia · RS rating 92 · As of 2026-10-14
| Price | 3.65 AUD |
|---|---|
| 1-day change | -1.6% |
| RS rating (overall / 1M / 3M / 12M) | 92 / 85 / 78 / 89 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 41 / 70 / 28 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +11.0% |
| Market cap (USD) | $266.4M |